{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T22:12:48Z","timestamp":1794867168525,"version":"4.9.1"},"reference-count":182,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:00:00Z","timestamp":1781654400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"GlaxoSmithKline"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Vaccines"],"published-print":{"date-parts":[[2026,12,31]]},"DOI":"10.1080\/14760584.2026.2684962","type":"journal-article","created":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T14:27:32Z","timestamp":1780928852000},"update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":2,"title":["From burden to benefit: overcoming barriers to immunization in adults, with a focus on respiratory syncytial virus"],"prefix":"10.1080","volume":"25","author":[{"given":"Cl\u00e1udia","family":"Vicente","sequence":"first","affiliation":[{"name":"Respiratory Group of the Portuguese Association of General and Family Medicine (GRESP\/APMGF)","place":["Coimbra, Portugal"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filipe","family":"Froes","sequence":"additional","affiliation":[{"name":"Hospital Pulido Valente","place":["Lisbon, Portugal"]},{"name":"Portuguese Society of Pulmonology (SPP)","place":["Lisbon, Portugal"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pier Luigi","family":"Lopalco","sequence":"additional","affiliation":[{"name":"University of Salento","place":["Lecce, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Heffernan","sequence":"additional","affiliation":[{"name":"King\u2019s College","place":["London, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramin","family":"Nilforooshan","sequence":"additional","affiliation":[{"name":"University of Surrey","place":["Guildford, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Friederike","family":"Martin","sequence":"additional","affiliation":[{"name":"Harvard Medical School","place":["Boston, USA"]},{"name":"Charit\u00e9 Universit\u00e4tsmedizin Berlin","place":["Berlin, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Leroux-Roels","sequence":"additional","affiliation":[{"name":"Ghent University Hospital","place":["Ghent, Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lior","family":"Nesher","sequence":"additional","affiliation":[{"name":"Soroka University Medical Center, Ben-Gurion University of the Negev","place":["Beersheba, Israel"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"D\u00e9planque","sequence":"additional","affiliation":[{"name":"GSK","place":["Wavre, Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nidhi","family":"Dani","sequence":"additional","affiliation":[{"name":"GSK","place":["Zug, Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Coelho","sequence":"additional","affiliation":[{"name":"GSK","place":["Alg\u00e9s, Portugal"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuno","family":"Pinto de Castro","sequence":"additional","affiliation":[{"name":"GSK","place":["Wavre, Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kayhan","family":"Tayarani-Binazir","sequence":"additional","affiliation":[{"name":"GSK","place":["London, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,6,17]]},"reference":[{"key":"e_1_3_6_3_1","unstructured":"World Health Organization. Respiratory syncytial virus (RSV). 2025 [cited 2025 Dec 8]. Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/respiratory-syncytial-virus-(rsv)"},{"key":"e_1_3_6_4_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiz059"},{"key":"e_1_3_6_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/irv.13031"},{"key":"e_1_3_6_6_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciab595"},{"key":"e_1_3_6_7_1","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofad513"},{"key":"e_1_3_6_8_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiad510"},{"key":"e_1_3_6_9_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11882-025-01194-w"},{"key":"e_1_3_6_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pcad.2025.06.010"},{"key":"e_1_3_6_11_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa730"},{"key":"e_1_3_6_12_1","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2025.30.10.2400364"},{"key":"e_1_3_6_13_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40121-024-01081-3"},{"key":"e_1_3_6_14_1","doi-asserted-by":"publisher","DOI":"10.1080\/14737167.2024.2441867"},{"key":"e_1_3_6_15_1","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2019.24.45.1900140"},{"key":"e_1_3_6_16_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiab452"},{"key":"e_1_3_6_17_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40121-025-01217-z"},{"key":"e_1_3_6_18_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40121-023-00758-5"},{"key":"e_1_3_6_19_1","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.01816-15"},{"key":"e_1_3_6_20_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiad012"},{"key":"e_1_3_6_21_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiae346"},{"key":"e_1_3_6_22_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciy991"},{"key":"e_1_3_6_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2020.11.185"},{"key":"e_1_3_6_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2023.105399"},{"key":"e_1_3_6_25_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciad031"},{"key":"e_1_3_6_26_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2022-060805"},{"key":"e_1_3_6_27_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.4954"},{"key":"e_1_3_6_28_1","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2023.1148531"},{"key":"e_1_3_6_29_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-025-04249-x"},{"key":"e_1_3_6_30_1","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvaf092"},{"key":"e_1_3_6_31_1","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0160-2025"},{"key":"e_1_3_6_32_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2025.47618"},{"key":"e_1_3_6_33_1","doi-asserted-by":"publisher","DOI":"10.1111\/irv.13043"},{"key":"e_1_3_6_34_1","doi-asserted-by":"publisher","DOI":"10.1111\/irv.12929"},{"key":"e_1_3_6_35_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.50634"},{"key":"e_1_3_6_36_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-018-3066-1"},{"key":"e_1_3_6_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)61382-8"},{"key":"e_1_3_6_38_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2222.2008.03157.x"},{"key":"e_1_3_6_39_1","unstructured":"World Health Organization. Ageing and health. [cited 2026 Feb 12]. Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/ageing-and-health"},{"key":"e_1_3_6_40_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-13562-y"},{"key":"e_1_3_6_41_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-66184-y"},{"key":"e_1_3_6_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pt.2018.07.004"},{"key":"e_1_3_6_43_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41579-021-00639-z"},{"key":"e_1_3_6_44_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-47118-6"},{"key":"e_1_3_6_45_1","unstructured":"European Medicines Agency. First vaccine to protect older adults from respiratory syncytial virus (RSV) infection. 2023 [cited 2025 Nov 4]. Available from: https:\/\/www.ema.europa.eu\/en\/news\/first-vaccine-protect-older-adults-respiratory-syncytial-virus-rsv-infection"},{"key":"e_1_3_6_46_1","unstructured":"US Food and Drug Administration. FDA approves first respiratory syncytial virus (RSV) vaccine. 2023 [cited 2025 Nov 4]. Available from: https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-first-respiratory-syncytial-virus-rsv-vaccine"},{"key":"e_1_3_6_47_1","unstructured":"European Medicines Agency. Arexvy summary of product characteristics. 2026 [cited 2026 Mar 10]. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/arexvy-epar-product-information_en.pdf"},{"key":"e_1_3_6_48_1","unstructured":"European Medicines Agency. Abrysvo summary of product characteristics. 2025 [cited 2025 Nov 4]. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/abrysvo-epar-product-information_en.pdf"},{"key":"e_1_3_6_49_1","unstructured":"European Medicines Agency. mRESVIA summary of product characteristics. 2025 [cited 2025 Nov 4]. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/mresvia-epar-product-information_en.pdf"},{"key":"e_1_3_6_50_1","unstructured":"US Food and Drug Administration. AREXVY (respiratory syncytial virus vaccine adjuvanted) for injectable suspension for intramuscular use prescribing information. 2025 [cited 2025 Nov 4]. Available from: https:\/\/www.fda.gov\/files\/vaccines%2C%20blood%20%26%20biologics\/published\/Package-Insert-AREXVY.pdf"},{"key":"e_1_3_6_51_1","unstructured":"US Food and Drug Administration. ABRYSVO (respiratory syncytial virus vaccine) for injection for intramuscular use prescribing information. 2025 [cited 2025 Nov 4]. Available from: https:\/\/www.fda.gov\/media\/168889\/download"},{"key":"e_1_3_6_52_1","unstructured":"US Food and Drug Administration. MRESVIA (respiratory syncytial virus vaccine) injectable suspension for intramuscular use prescribing information. 2025 [cited 2025 Nov 4]. Available from: https:\/\/www.fda.gov\/files\/vaccines%2C%20blood%20%26%20biologics\/published\/Package-Insert-MRESVIA_1.pdf"},{"key":"e_1_3_6_53_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp2216358"},{"key":"e_1_3_6_54_1","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.01432-25"},{"key":"e_1_3_6_55_1","unstructured":"Public Health Agency of Canada. Summary of National Advisory Committee on Immunization (NACI) statement of March 13 2025: updated guidance on respiratory syncytial virus (RSV) vaccines for older adults including the expanded use of RSVPreF3 for individuals 50 to 59 years of age and use of the new mRNA-1345 vaccine. 2025 [cited 2025 Dec 8]. Available from: https:\/\/publications.gc.ca\/collections\/collection_2025\/aspc-phac\/HP40-384-2025-1-eng.pdf"},{"key":"e_1_3_6_56_1","unstructured":"Bundesamt f\u00fcr Gesundheit. Richtlinien und Empfehlungen - Empfehlungen zur Impfung und Immunisierung gegen das Respiratorische Synzytial Virus (RSV). 2025 [cited 2025 Nov 4]. Available from: https:\/\/www.bag.admin.ch\/dam\/de\/sd-web\/ROjGfpexE5Pp\/de_BAG_Bulletin_36-25_RSV_bf.pdf"},{"key":"e_1_3_6_57_1","unstructured":"UK Department of Health & Social Care. Respiratory syncytial virus (RSV) immunisation programme for adults aged 80 years and older: JCVI advice. 2025 Jul 16 [cited 2025 Nov 4]. Available from https:\/\/www.gov.uk\/government\/publications\/rsv-immunisation-programme-jcvi-advice-16-july-2025\/respiratory-syncytial-virus-rsv-immunisation-programme-for-adults-aged-80-years-and-older-jcvi-advice-16-july-2025"},{"key":"e_1_3_6_58_1","unstructured":"Superior Health Council. Vaccination against RSV for older adults SHC N\u00b09837. 2024 [cited 2025 Nov 4]. Available from: https:\/\/www.hgr-css.be\/file\/download\/d82e0fe1-90f8-4462-89e4-2297fecfe3dc\/arLom1a0psGjiZ13SINUSuDk5k4i6NFdE3baUkisE3d.pdf"},{"key":"e_1_3_6_59_1","unstructured":"Centers for Disease Control and Prevention. RSV vaccine guidance for adults. 2025 [cited 2025 Dec 8]. Available from: https:\/\/www.cdc.gov\/rsv\/hcp\/vaccine-clinical-guidance\/adults.html"},{"key":"e_1_3_6_60_1","unstructured":"Folkehelseinstituttet. RSV vaccine \u2013 a guide for healthcare professionals. 2025 [cited 2025 Nov 4]. Available from: https:\/\/www.fhi.no\/va\/vaksinasjonshandboka\/vaksiner-mot-de-enkelte-sykdommene\/rs-virusvaksine\/"},{"key":"e_1_3_6_61_1","unstructured":"Royal College of Physicians of Ireland National Immunisation Advisory Committee. Recommendations for passive immunisation and vaccination against respiratory syncytial virus in infants children and older adults. 2023 [cited 2025 Dec 8]. Available from: https:\/\/www.nitag-resource.org\/sites\/default\/files\/2023-12\/2023.10.12_NIAC_evidence_synthesis_and_recommendations_re._R.pdf"},{"key":"e_1_3_6_62_1","unstructured":"Robert Koch Institut. 4 2025: current data and information on infectious diseases and public health. Epidemiologisches Bulletin. 2025 [cited 2025 Nov 4]. Available from: https:\/\/www.rki.de\/EN\/Topics\/Infectious-diseases\/Immunisation\/STIKO\/STIKO-recommendations\/Downloads\/04_25_english.pdf?__blob=publicationFile&v=2"},{"key":"e_1_3_6_63_1","unstructured":"Haute Autorit\u00e9 de Sant\u00e9. Strat\u00e9gie vaccinale de pr\u00e9vention des infections par le VRS chez l\u2019adulte \u00e2g\u00e9 de 60 ans et plus. 2024 [cited 2025 Nov 4]. Available from: https:\/\/www.has-sante.fr\/jcms\/p_3460918\/fr\/strategie-vaccinale-de-prevention-des-infections-par-le-vrs-chez-l-adulte-age-de-60-ans-et-plus"},{"key":"e_1_3_6_64_1","unstructured":"Folkh\u00e4lsomyndigheten. Recommended vaccinations. 2025 [cited 2025 Nov 4]. Available from: https:\/\/www.folkhalsomyndigheten.se\/the-public-health-agency-of-sweden\/communicable-disease-control\/vaccinations\/recommended-vaccinations\/"},{"key":"e_1_3_6_65_1","unstructured":"Official Journal of the Minister of Health (Poland). Komunikat g\u0142\u00f3wnego inspektora sanitarnego z dnia 31 pa\u017adziernika 2024 r. W sprawie programu szczepie\u0144 ochronnych na rok. 2025 [cited 2025 Dec 8]. Available from: https:\/\/www.gov.pl\/attachment\/83bef042-106b-4228-a011-56bcb58470bb"},{"key":"e_1_3_6_66_1","unstructured":"Bundesministerium Arbeit - Soziales - Gesundheit - Pflege und Konsumentenschutz. Impfplan \u00d6sterreich 2025\/2026. 2025 [cited 2025 Dec 18]. Available from: https:\/\/www.sozialministerium.gv.at\/Themen\/Gesundheit\/Impfen\/impfplan.html"},{"key":"e_1_3_6_67_1","unstructured":"Greece Ministry of Health. \u0398\u0395\u039c\u0391: \u00ab\u03a4\u03c1\u03bf\u03c0\u03bf\u03c0\u03bf\u03af\u03b7\u03c3\u03b7 \u0395\u03b8\u03bd\u03b9\u03ba\u03bf\u03cd \u03a0\u03c1\u03bf\u03b3\u03c1\u03ac\u03bc\u03bc\u03b1\u03c4\u03bf\u03c2 \u0395\u03bc\u03b2\u03bf\u03bb\u03b9\u03b1\u03c3\u03bc\u03ce\u03bd \u0395\u03bd\u03b7\u03bb\u03af\u03ba\u03c9\u03bd 2024. \u03a7\u03c1\u03bf\u03bd\u03bf\u03b4\u03b9\u03ac\u03b3\u03c1\u03b1\u03bc\u03bc\u03b1 \u03ba\u03b1\u03b9 \u03a3\u03c5\u03c3\u03c4\u03ac\u03c3\u03b5\u03b9\u03c2\u00bb [SUBJECT: \u201cAmendment of the National Adult Vaccination Program 2024. Timetable and recommendations\u201d]. 2024 [cited 2025 Nov 4]. Available from: https:\/\/www.nomotelia.gr\/photos\/File\/44011-24.pdf"},{"key":"e_1_3_6_68_1","unstructured":"Ministry of Health. \u05d4\u05e0\u05d3\u05d5\u05df: \u05ea\u05e8\u05db\u05d9\u05d1 AREXVY \u05d7\u05d9\u05e1\u05d5\u05df \u05e0\u05d2\u05d3 RSV \u05dc\u05de\u05d1\u05d5\u05d2\u05e8\u05d9\u05dd \u05de\u05ea\u05d5\u05e6\u05e8\u05ea GSK [Subject: AREXVY vaccine an adult RSV vaccine manufactured by GSK]. 2024 [cited 2025 Sep]. Available from: https:\/\/www.gov.il\/BlobFolder\/policy\/adult\/he\/files_publications_units_epidemiology_vaccine_guidelines_371_RSV_vaccine.pdf"},{"key":"e_1_3_6_69_1","unstructured":"Saudi Arabia Ministry of Health. Respiratory syncytial virus (RSV) vaccine. 2025 [cited 2025 Nov 4]. Available from: https:\/\/www.moh.gov.sa\/en\/HealthAwareness\/EducationalContent\/vaccination\/Pages\/Respiratory-Syncytial-Virus-RSV-Vaccine.aspx"},{"key":"e_1_3_6_70_1","unstructured":"Centre for Health Protection. Scientific committee on vaccine preventable diseases. Interim consensus on the use of respiratory syncytial virus vaccines in Hong Kong (as of 17 January 2025). 2025 [cited 2025 Dec 8]. Available from: https:\/\/www.chp.gov.hk\/files\/pdf\/interim_consensus_on_the_use_of_respiratory_syncytial_virus_vaccines_in_hong_kong_jan2025.pdf"},{"key":"e_1_3_6_71_1","unstructured":"Taiwan Centers for Disease Control. Respiratory syndrome virus vaccine (RSV vaccine). 2025 [cited 2025 Dec 8]. Available from: https:\/\/www.cdc.gov.tw\/En\/Category\/Page\/HMYG9wwEPFHjjpE8D6R31Q"},{"key":"e_1_3_6_72_1","unstructured":"Australian Government. Department of Health Disability and Ageing. Respiratory syncytial virus (RSV). 2025 [cited 2025 Dec 8]. Available from: https:\/\/immunisationhandbook.health.gov.au\/contents\/vaccine-preventable-diseases\/respiratory-syncytial-virus-rsv"},{"key":"e_1_3_6_73_1","unstructured":"Comit\u00e9 Asesor de Vacunas y Estrategias de Inmunizaci\u00f3n. Recomendaci\u00f3n del cavei sobre incorporaci\u00f3n de vacunaci\u00f3n contra virus respiratorio sincicial en adultos mayores y embarazadas en el programa nacional de inmunizaciones. 2023 [cited 2025 Dec 8]. Available from: https:\/\/www.nitag-resource.org\/sites\/default\/files\/2024-01\/Recomendacion-del-CAVEI-sobre-incorporacion-de-vacunacion-contra-virus-respiratorio-sincicial-en-adultos-mayores-y-embarazadas-1.pdf"},{"key":"e_1_3_6_74_1","unstructured":"Sundhedsstyrelsen. Tilskud til vacciner til visse persongrupper - Vaccine mod RSV [Subsidies for vaccines for certain groups of people - RSV vaccine]. [cited 2026 Apr 9]. Available from: https:\/\/www.sst.dk\/vidensbase\/forebyggelse\/vaccination\/tilskud-til-vacciner-til-visse-persongrupper"},{"key":"e_1_3_6_75_1","unstructured":"Global Initiative for Asthma. Global strategy for asthma management and prevention (2025 update). [cited 2025 Nov 28]. Available from: https:\/\/ginasthma.org\/2025-gina-strategy-report\/"},{"key":"e_1_3_6_76_1","unstructured":"Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis management and prevention of chronic obstructive lung disease: 2025 report 2025. [cited 2025 Nov 28]. Available from: https:\/\/goldcopd.org\/wp-content\/uploads\/2024\/11\/GOLD-2025-Report-v1.0-15Nov2024_WMV.pdf"},{"key":"e_1_3_6_77_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.24.00032"},{"key":"e_1_3_6_78_1","unstructured":"Public Health Agency of Canada. Summary of National Advisory Committee on Immunization (NACI) statement of July 12 2024: statement on the prevention of respiratory syncytial virus disease in older adults. 2024 [cited 2025 Dec 8]. Available from: https:\/\/www.canada.ca\/en\/public-health\/services\/publications\/vaccines-immunization\/national-advisory-committee-immunization-summary-statement-prevention-rsv-disease-older-adults.html"},{"key":"e_1_3_6_79_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2209604"},{"key":"e_1_3_6_80_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2213836"},{"key":"e_1_3_6_81_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2307079"},{"key":"e_1_3_6_82_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiad546"},{"key":"e_1_3_6_83_1","unstructured":"Das R. Update on Moderna\u2019s RSV vaccine mRESVIA (mRNA-1345) in adults \u226560 years of age. Advisory Committee on Immunization Practices (ACIP); 2024 [cited 2025 Nov 4]. Available from: https:\/\/www.cdc.gov\/acip\/downloads\/slides-2024-06-26-28\/04-RSV-Adult-Das-508.pdf"},{"key":"e_1_3_6_84_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(25)00048-7"},{"key":"e_1_3_6_85_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciae010"},{"key":"e_1_3_6_86_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaf061"},{"key":"e_1_3_6_87_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc2311560"},{"issue":"1","key":"e_1_3_6_88_1","first-page":"S1","article-title":"Abstract 1151. Efficacy of the AS01E-adjuvanted respiratory syncytial virus prefusion F protein vaccine in adults \u226560 years of age with diabetes and\/or obesity across 3 RSV seasons","volume":"68","author":"Hulstrom V","year":"2025","unstructured":"Hulstrom V, Papi A, Incalzi RA, et al. Abstract 1151. Efficacy of the AS01E-adjuvanted respiratory syncytial virus prefusion F protein vaccine in adults \u226560 years of age with diabetes and\/or obesity across 3 RSV seasons. Diabetologia. 2025;68(Suppl 1):S1\u2013S754.","journal-title":"Diabetologia"},{"issue":"69","key":"e_1_3_6_89_1","first-page":"PA3912","article-title":"AS01E-adjuvanted RSV prefusion F protein vaccine (adjuvanted RSVPreF3) reduces RSV acute respiratory illness (ARI)-related complications and medication use in participants with COPD or asthma","volume":"66","author":"Papi A","year":"2025","unstructured":"Papi A, Halpin DMG, Feldman RG, et al. AS01E-adjuvanted RSV prefusion F protein vaccine (adjuvanted RSVPreF3) reduces RSV acute respiratory illness (ARI)-related complications and medication use in participants with COPD or asthma. Eur Respir J. 2025;66(suppl 69):PA3912.","journal-title":"Eur Respir J"},{"key":"e_1_3_6_90_1","volume-title":"13th International RSV Symposium 2025","author":"Cabrera ES","year":"2025","unstructured":"Cabrera ES, Mathews S, Narejos P\u00e9rez S, et al. The AS01E-adjuvanted RSV prefusion F protein vaccine (adjuvanted RSVPreF3) attenuates the severity of RSV-associated disease in breakthrough infections in adults aged 60 years and above: analysis at the end of 3 RSV seasons. 13th International RSV Symposium 2025; Brazil. Iguazu Falls; 2025 Mar 12\u201315."},{"key":"e_1_3_6_91_1","doi-asserted-by":"publisher","DOI":"10.1111\/irv.13236"},{"key":"e_1_3_6_92_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(24)01738-0"},{"key":"e_1_3_6_93_1","volume-title":"6th ESCMID Conference on Vaccines","author":"Tseng HF","year":"2025","unstructured":"Tseng HF, Qian L, Sy LS, et al. Abstract #00004: real-world effectiveness of adjuvanted RSVPreF3 vaccine in preventing RSV-associated lower respiratory tract disease (LRTD) hospitalisation in adults aged \u226560 years: early results of a test-negative design study. 6th ESCMID Conference on Vaccines; 2025 Sep 10\u201313; Lisbon, Portugal."},{"key":"e_1_3_6_94_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.50832"},{"key":"e_1_3_6_95_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(24)00796-5"},{"key":"e_1_3_6_96_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2025.8322"},{"key":"e_1_3_6_97_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2024.15775"},{"key":"e_1_3_6_98_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2025.15896"},{"key":"e_1_3_6_99_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(25)00346-0"},{"key":"e_1_3_6_100_1","unstructured":"Public Health Scotland. UK-wide report highlights success of Scotland\u02bcs RSV vaccination programme. 2025 [cited 2025 Dec 8]. Available from: https:\/\/publichealthscotland.scot\/news\/2025\/july\/uk-wide-report-highlights-success-of-scotland-s-rsv-vaccination-programme\/"},{"key":"e_1_3_6_101_1","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2026.2641671"},{"key":"e_1_3_6_102_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2025.15405"},{"key":"e_1_3_6_103_1","volume-title":"Presented at ReSViNET","author":"Singer D","year":"2026","unstructured":"Singer D, Steffens A, La E, et al. Effectiveness of adjuvanted RSVPreF3 vaccine in preventing major adverse cardiovascular events, severe asthma exacerbations, and severe COPD exacerbations among US adults aged 60 years and older. Presented at ReSViNET; 2026 Feb 17\u201320; Rome, Italy; 2026 Feb 17\u201320."},{"key":"e_1_3_6_104_1","doi-asserted-by":"publisher","DOI":"10.3201\/eid3202.251520"},{"key":"e_1_3_6_105_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanepe.2026.101623"},{"key":"e_1_3_6_106_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7229a4"},{"key":"e_1_3_6_107_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7332e1"},{"key":"e_1_3_6_108_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2025.2535755"},{"key":"e_1_3_6_109_1","unstructured":"Centers for Disease Control and Prevention. RSVVaxView. Respiratory syncytial virus (RSV) vaccination coverage adults 75 years and older by jurisdiction United States. 2025 [cited 2025 Dec 8]. Available from: https:\/\/www.cdc.gov\/rsvvaxview\/dashboard\/adults-60-admin-coverage-jurisdiction.html"},{"key":"e_1_3_6_110_1","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2024.2436183"},{"key":"e_1_3_6_111_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciad658"},{"key":"e_1_3_6_112_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2024.02.041"},{"key":"e_1_3_6_113_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2024.2432745"},{"key":"e_1_3_6_114_1","unstructured":"UK Health Security Agency. RSV vaccine coverage report in older adults in England: October 2025. [cited 2025 Dec 8]. Available from: https:\/\/www.gov.uk\/government\/publications\/rsv-older-adults-vaccination-coverage-in-england\/rsv-vaccine-coverage-report-in-older-adults-in-england-october-2025"},{"key":"e_1_3_6_115_1","unstructured":"National Health Service. RSV vaccine. [cited 2026 Feb 16]. Available from: https:\/\/www.nhs.uk\/vaccinations\/rsv-vaccine\/"},{"key":"e_1_3_6_116_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)31558-0"},{"key":"e_1_3_6_117_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2025.128114"},{"key":"e_1_3_6_118_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2022.2127290"},{"key":"e_1_3_6_119_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2024.2303796"},{"key":"e_1_3_6_120_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40121-025-01119-0"},{"key":"e_1_3_6_121_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0330763"},{"key":"e_1_3_6_122_1","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2023.38.e326"},{"key":"e_1_3_6_123_1","doi-asserted-by":"publisher","DOI":"10.1111\/risa.13942"},{"key":"e_1_3_6_124_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(22)00320-6"},{"key":"e_1_3_6_125_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamahealthforum.2025.2223"},{"key":"e_1_3_6_126_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2025.2543167"},{"key":"e_1_3_6_127_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-024-01019-3"},{"key":"e_1_3_6_128_1","unstructured":"European Centre for Disease Prevention and Control. COVID-19 vaccination coverage in the EU\/EEA during the 2023\u201324 season campaigns 2024 [cited 2025 Dec 8]. Available from: https:\/\/www.ecdc.europa.eu\/sites\/default\/files\/documents\/covid19-vaccination-coverage-2023-2024.pdf"},{"key":"e_1_3_6_129_1","doi-asserted-by":"publisher","DOI":"10.2196\/jmir.1157"},{"key":"e_1_3_6_130_1","unstructured":"World Health Organization. Global childhood vaccination coverage holds steady yet over 14 million infants remain unvaccinated \u2013 WHO. UNICEF. 2025 [cited 2025 Dec 8]. Available from: https:\/\/www.who.int\/news\/item\/15-07-2025-global-childhood-vaccination-coverage-holds-steady-yet-over-14-million-infants-remain-unvaccinated-who-unicef"},{"key":"e_1_3_6_131_1","unstructured":"Centers for Disease Control and Prevention. Manual for the surveillance of vaccine-preventable diseases. Chapter 1: diphtheria. 2025 [cited 2025 Dec 8]. Available from: https:\/\/www.cdc.gov\/surv-manual\/php\/table-of-contents\/chapter-1-diphtheria.html"},{"key":"e_1_3_6_132_1","unstructured":"Centers for Disease Control and Prevention. Tetanus. Tetanus vaccination. 2025 [cited 2025 Dec 8]. Available from: https:\/\/www.cdc.gov\/tetanus\/vaccines\/index.html"},{"key":"e_1_3_6_133_1","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268813000071"},{"key":"e_1_3_6_134_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2020.11.002"},{"key":"e_1_3_6_135_1","unstructured":"Centers for Disease Control and Prevention. Shingles (herpes zoster). Clinical overview of shingles (herpes zoster). 2024 [cited 2025 Dec 8]. Available from: https:\/\/www.cdc.gov\/shingles\/hcp\/clinical-overview\/index.html"},{"key":"e_1_3_6_136_1","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2015-206780"},{"key":"e_1_3_6_137_1","doi-asserted-by":"publisher","DOI":"10.1080\/07853890.2019.1588470"},{"key":"e_1_3_6_138_1","unstructured":"United Nations. Decade of healthy aging - the platform. [cited 2025 Nov 4]. Available from: https:\/\/www.decadeofhealthyageing.org\/"},{"key":"e_1_3_6_139_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-024-18694-5"},{"key":"e_1_3_6_140_1","doi-asserted-by":"publisher","DOI":"10.1177\/21501319231186500"},{"key":"e_1_3_6_141_1","doi-asserted-by":"publisher","DOI":"10.4065\/mcp.2010.0575"},{"key":"e_1_3_6_142_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejim.2023.07.008"},{"key":"e_1_3_6_143_1","doi-asserted-by":"publisher","DOI":"10.1080\/07853890.2017.1417632"},{"key":"e_1_3_6_144_1","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines11071217"},{"key":"e_1_3_6_145_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.chb.2021.107176"},{"key":"e_1_3_6_146_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2017.12.016"},{"key":"e_1_3_6_147_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0298407"},{"key":"e_1_3_6_148_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvacx.2022.100174"},{"key":"e_1_3_6_149_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2022.2041360"},{"key":"e_1_3_6_150_1","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2025.1537255"},{"key":"e_1_3_6_151_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40520-025-02968-y"},{"key":"e_1_3_6_152_1","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines13050459"},{"key":"e_1_3_6_153_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-025-08800-x"},{"key":"e_1_3_6_154_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-025-01172-3"},{"key":"e_1_3_6_155_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.872542"},{"key":"e_1_3_6_156_1","unstructured":"Review on Antimicrobial Resistance. Tackling drug-resistant infections globally: final report and recommendations. 2016 [cited 2025 Dec 8]. Available from: https:\/\/amr-review.org\/sites\/default\/files\/160518_Final%20paper_with%20cover.pdf"},{"key":"e_1_3_6_157_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgh-2022-011341"},{"key":"e_1_3_6_158_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2024.06.017"},{"key":"e_1_3_6_159_1","unstructured":"World Health Organization. Estimating the impact of vaccines in reducing antimicrobial resistance and antibiotic use: technical report 2024. [cited 2025 Nov 4]. Available from: https:\/\/www.who.int\/publications\/i\/item\/9789240098787"},{"key":"e_1_3_6_160_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkaf043"},{"key":"e_1_3_6_161_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2112410119"},{"key":"e_1_3_6_162_1","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2021.26.17.2001195"},{"key":"e_1_3_6_163_1","doi-asserted-by":"publisher","DOI":"10.4161\/hv.26797"},{"key":"e_1_3_6_164_1","unstructured":"World Health Organization. Vaccinating at every age is key to unlocking the full potential of immunization. 2025 [cited 2025 Dec 8]. Available from: https:\/\/www.who.int\/news\/item\/05-06-2025-vaccinating-at-every-age-is-key-to-unlocking-the-full-potential-of-immunization"},{"issue":"1","key":"e_1_3_6_165_1","first-page":"15","article-title":"Use of standing orders programs to increase adult vaccination rates","volume":"49","author":"McKibben LJ","year":"2000","unstructured":"McKibben LJ, Stange PV, Sneller VP, et al. Use of standing orders programs to increase adult vaccination rates. MMWR Recomm Rep. 2000;49(RR\u20131):15\u201316.","journal-title":"MMWR Recomm Rep"},{"key":"e_1_3_6_166_1","doi-asserted-by":"publisher","DOI":"10.3390\/healthcare13141667"},{"key":"e_1_3_6_167_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2019.09.016"},{"key":"e_1_3_6_168_1","doi-asserted-by":"publisher","DOI":"10.3389\/fragi.2023.1200397"},{"key":"e_1_3_6_169_1","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines10050800"},{"key":"e_1_3_6_170_1","doi-asserted-by":"publisher","DOI":"10.1002\/iid3.1259"},{"key":"e_1_3_6_171_1","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines11101611"},{"key":"e_1_3_6_172_1","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines10020297"},{"key":"e_1_3_6_173_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2021-068632"},{"key":"e_1_3_6_174_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-024-10377-1"},{"key":"e_1_3_6_175_1","unstructured":"Centers for Disease Control and Prevention. Vaccines & immunizations. Altered immunocompetence. 2024 [cited 2025 Dec 8]. Available from: https:\/\/www.cdc.gov\/vaccines\/hcp\/imz-best-practices\/altered-immunocompetence.html"},{"key":"e_1_3_6_176_1","unstructured":"Centers for Disease Control and Prevention. Vaccines & immunizations. Adult immunization schedule notes. 2025 [cited 2025 Dec 8]. Available from: https:\/\/www.cdc.gov\/vaccines\/hcp\/imz-schedules\/adult-notes.html"},{"key":"e_1_3_6_177_1","unstructured":"Centers for Disease Control and Prevention. Haemophilus influenzae disease. Hib Vaccination. 2024 [cited 2025 Sep]. Available from: https:\/\/www.cdc.gov\/hi-disease\/vaccines\/index.html"},{"key":"e_1_3_6_178_1","unstructured":"Centers for Disease Control and Prevention. Shingles (herpes zoster). Shingles vaccine recommendations. 2024 [cited 2025 Dec 8]. Available from: https:\/\/www.cdc.gov\/shingles\/hcp\/vaccine-considerations\/index.html"},{"key":"e_1_3_6_179_1","unstructured":"Centers for Disease Control and Prevention. Vaccines for moderately to severely immunocompromised people. 2025 [cited 2025 Dec 8]. Available from: https:\/\/www.cdc.gov\/covid\/vaccines\/immunocompromised-people.html"},{"key":"e_1_3_6_180_1","unstructured":"Government of Canada. Immunization of immunocompromised persons: Canadian immunization guide. 2018 [cited 2025 Dec 8]. Available from: https:\/\/www.canada.ca\/en\/public-health\/services\/publications\/healthy-living\/canadian-immunization-guide-part-3-vaccination-specific-populations\/page-8-immunization-immunocompromised-persons.html"},{"key":"e_1_3_6_181_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cit816"},{"key":"e_1_3_6_182_1","doi-asserted-by":"crossref","unstructured":"Nellore A Goepfert P Tan CS et al. IDSA 2025 guidelines on the use of vaccines for the prevention of seasonal COVID-19 influenza and RSV infections in immunocompromised patients. 2025 [cited 2025 Dec 18]. Available from: https:\/\/www.idsociety.org\/Seasonal-RTI-Vaccinations-in-Immunocompromised-Patients\/","DOI":"10.1093\/cid\/ciag114"},{"key":"e_1_3_6_183_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciag117"},{"key":"e_1_3_6_184_1","unstructured":"World Health Organization. Vaccination and trust: how concerns arise and the role of communication in mitigating crises. 2017 [cited 2025 Dec 8]. Available from: https:\/\/cdn.who.int\/media\/docs\/default-source\/documents\/publications\/vaccines-and-trust78f2bc69-8a27-4657-9b2d-13d3075da41d.pdf?sfvrsn=b71b557d_1&download=true"}],"container-title":["Expert Review of Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14760584.2026.2684962","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T08:42:45Z","timestamp":1781685765000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14760584.2026.2684962"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,17]]},"references-count":182,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12,31]]}},"alternative-id":["10.1080\/14760584.2026.2684962"],"URL":"https:\/\/doi.org\/10.1080\/14760584.2026.2684962","relation":{},"ISSN":["1476-0584","1744-8395"],"issn-type":[{"value":"1476-0584","type":"print"},{"value":"1744-8395","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,17]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierv20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierv20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-12-22","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-20","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-17","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"2684962"}}